[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647
Sort by:

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 provides an overview of the...

April 2021 140 pages

Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Bile Duct Cancer...

April 2021 30 pages

Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Biliary T...

April 2021 95 pages

Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021 provides an overview of the...

April 2021 115 pages

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Hormone Refractory (Castration Resistant, Androgen...

April 2021 325 pages

Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Liver Cancer pipeline lan...

April 2021 65 pages

Metastatic Melanoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Metastatic Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape. The...

April 2021 425 pages

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeli...

April 2021 115 pages

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Canc...

April 2021 160 pages

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pip...

April 2021 95 pages

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cel...

April 2021 170 pages

Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021 provides an...

April 2021 130 pages

Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Uveal Melanoma pipeli...

April 2021 65 pages

Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021

 US$ 3,000.00

Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021 SUMMARY Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021 provides in depth analysis on Methyl CpG Binding Protein 2 (...

April 2021 35 pages

Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Methylmalonic Ac...

April 2021 35 pages

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) - Drugs in Development, 2021

 US$ 3,000.00

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) - Drugs in Development, 2021 SUMMARY Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomera...

April 2021 30 pages

microRNA 21 (MIR21) - Drugs in Development, 2021

 US$ 3,000.00

microRNA 21 (MIR21) - Drugs in Development, 2021 SUMMARY microRNA 21 (MIR21) - Drugs in Development, 2021 provides in depth analysis on microRNA 21 (MIR21) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021

 US$ 3,000.00

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021 SUMMARY Microtubule Associated Protein Tau (Neurofibrillary Tang...

April 2021 150 pages

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021

 US$ 3,000.00

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021 SUMMARY Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Developmen...

April 2021 40 pages

Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Mitochondrial Di...

April 2021 60 pages

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Mito...

April 2021 35 pages

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021 SUMMARY Mitogen Activat...

April 2021 30 pages

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Mitog...

April 2021 35 pages

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021 SUMMARY Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development,...

April 2021 35 pages

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021

 US$ 3,000.00

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 SUMMARY Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021 SUMMARY Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Molluscum Contagiosu...

April 2021 35 pages

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021

 US$ 3,000.00

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4)...

April 2021 30 pages

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021

 US$ 3,000.00

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021 SUMMARY Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or...

April 2021 30 pages

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 SUMMARY Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Motor Neuron...

April 2021 30 pages

Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021 provides an overview o...

April 2021 30 pages

Movement Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Movement Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Movement Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Movement Disorders...

April 2021 40 pages

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021

 US$ 3,500.00

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021 SUMMARY Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OP...

April 2021 325 pages

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 SUMMARY Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 pr...

April 2021 30 pages

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) -...

April 2021 35 pages

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021 SUMMARY Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs...

April 2021 35 pages

Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021

 US$ 3,000.00

Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021 provides in depth analysis on Muscarinic Ace...

April 2021 75 pages

Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021

 US$ 3,000.00

Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 provides in depth analysis on Muscarinic Ace...

April 2021 65 pages

Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Muscle Atrophy pipeline landscape. The r...

April 2021 30 pages

Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Muscle Injury pipeline...

April 2021 30 pages

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 SUMMARY Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle I...

April 2021 75 pages

Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Muscle Spasm pipeline landscape. The report...

April 2021 30 pages

Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 SUMMARY Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Muscle Spasticity pi...

April 2021 50 pages

Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the...

April 2021 30 pages

Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Musculoskeleta...

April 2021 35 pages

Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Myalgia (Mus...

April 2021 30 pages

Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Mycobacterium avium Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the My...

April 2021 35 pages

Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Mycobacterium...

April 2021 50 pages

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021

 US$ 3,000.00

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021 SUMMARY Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secreto...

April 2021 30 pages

Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 provides an over...

April 2021 40 pages

Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021

 US$ 3,000.00

Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 SUMMARY Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 provides in depth analysis on Mycobacterium tubercul...

April 2021 30 pages

Filters

Clear all

Search

Categories

154
14,886
12,075
344
72
1,116

Publishers

72
1
3,298
1,760
342
155
531
292
33
4
2,060
635
92
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
84
4
26
50
1
141
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
81
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
26,041

Price

—

Date

—

Pages

—

Offers

44
5
1